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The prevalence of obesity has continued to rise over the past three decades leading
to significant increases in obesity-related medical care costs from metabolic and nonmetabolic sequelae. It is now clear that expansion of body fat leads to an increase in
inflammation with systemic effects on metabolism. In mouse models of diet-induced
obesity, there is also an expansion of bone marrow adipocytes. However, the persistence
of these changes after weight loss has not been well described. The objective of this
study was to investigate the impact of high-fat diet (HFD) and subsequent weight loss on
skeletal parameters in C57Bl6/J mice. Male mice were given a normal chow diet (ND) or
60% HFD at 6 weeks of age for 12, 16, or 20 weeks. A third group of mice was put on
HFD for 12 weeks and then on ND for 8 weeks to mimic weight loss. After these dietary
challenges, the tibia and femur were removed and analyzed by micro computed-tomography for bone morphology. Decalcification followed by osmium staining was used to
assess bone marrow adiposity, and mechanical testing was performed to assess bone
strength. After 12, 16, or 20 weeks of HFD, mice had significant weight gain relative to
controls. Body mass returned to normal after weight loss. Marrow adipose tissue (MAT)
volume in the tibia increased after 16 weeks of HFD and persisted in the 20-week HFD
group. Weight loss prevented HFD-induced MAT expansion. Trabecular bone volume
fraction, mineral content, and number were decreased after 12, 16, or 20 weeks of
HFD, relative to ND controls, with only partial recovery after weight loss. Mechanical
testing demonstrated decreased fracture resistance after 20 weeks of HFD. Loss of
mechanical integrity did not recover after weight loss. Our study demonstrates that HFD
causes long-term, persistent changes in bone quality, despite prevention of marrow
adipose tissue accumulation, as demonstrated through changes in bone morphology
and mechanical strength in a mouse model of diet-induced obesity and weight loss.
Keywords: obesity, bone, marrow adipose tissue, marrow fat, weight loss, leptin, high-fat diet, fracture
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INTRODUCTION

calorie restriction or “dieting.” Few studies have looked at weight
loss in rodent models through interventions of “switching” diet.
One study performed showed that switching back to a chow diet
following high-fat feeding could rescue bone loss (12); however,
the response of MAT and the interaction of MAT with bone loss
in these models was not examined.
The objective of this study was to investigate the interaction
between MAT and bone in the context of high-fat feeding and to
examine the response of these tissues to dietary weight loss. We
demonstrate that high-fat feeding leads to excess peripheral adiposity, MAT expansion, a reduction in bone mass and impaired
bone strength. Weight loss led to a significant reduction in whole
body adiposity and blocked MAT expansion; however, it failed
to completely rescue defects in skeletal morphology and biomechanics. This work begins to address the potential of adipose
tissue within the skeleton to have an impact on bone – working,
unlike peripheral fat, from the inside out.

Over the past two decades, the prevalence of obesity has increased
in Western countries (1, 2). In the United States, currently ~68.6%
of adults and approximately one-third (~31.8%) of children are
overweight or obese (3). Obesity is associated with comorbidities
including cardiovascular and metabolic disease, autoimmune
disorders and some cancers (1, 4–6). Recent work has suggested
that obesity is also detrimental to bone health (7–11), with skeletal changes that can persist even after weight loss (10, 12).
Previously, it was assumed that obesity had a purely positive
effect on bone mass (13–15); increased body weight provides
mechanical stimulation, resulting in skeletal loading and bone
accrual. However, juxtaposed to this, there is a newly recognized
metabolic component, as the adipose tissue itself can exert a
negative influence on bone (14). Indeed, increases in body mass
index (BMI) have been associated with decreased bone mineral
density (BMD) and increased fracture risk in obese adolescents
and adults (9, 16), and in obese children (17). The effect of obesity
on fracture risk is site specific. The presence of soft-tissue padding
from fat may contribute to decreased fracture risk in some areas
(e.g., hip) while unprotected sites, such as the extremities (e.g.,
humerus and ankle), have increased risk (18–20).
The cross-sectional nature of previous clinical studies can
only identify associations between obesity and bone, thus, rodent
models are widely utilized to explore the mechanisms underlying the relationship between obesity and the skeleton. It is well
established that high-fat feeding of mice leads to a reduction in
cancellous bone mass (7, 12, 21, 22). This may be mediated by
leptin-induced sympathetic tone, which has been implicated as
strong mediator of cancellous bone loss (23–25). By comparison, the cortical phenotype in response to high-fat diet (HFD)
in rodents remains unclear, with some studies indicating an
increase (11), no change (12, 21, 22, 26) or a reduction in cortical
bone mass (10, 27). Located within the skeleton are the bone
marrow adipocytes; recent studies suggest that marrow adipose
tissue (MAT) expansion occurs during high-fat feeding (28, 29).
Whether MAT expansion and bone loss are somehow linked during obesity is still unclear; some studies suggest that these lineages
are correlated (29–31) while Doucette et al. recently reported
MAT expansion during diet-induced obesity that occurred
independently of a bone phenotype (28).
In addition to the effects of obesity on bone, weight loss
interventions have also been shown to have detrimental effects
on bone metabolism, as reviewed by Brzozowska et al. (32). There
are a range of interventions including calorie-restricted diets,
exercise regimens, medications, and bariatric surgery (32, 33).
Each of these interventions aim to reduce body fat and improve
metabolic disease; the full extent to which these processes may
alter MAT and bone mass in the context of obesity are largely
unknown. Surgical interventions of bariatric surgery (Roux-en
Y gastric bypass, laparoscopic adjustable gastric banding, and
sleeve gastrectomy) have all been associated with a decline in
bone mass despite improvements in metabolic health (32). In
contrast to surgical weight loss, exercise has been shown to be
quite beneficial on bone density due to increased muscle loading (34–36). The most common initial intervention clinically is
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MATERIALS AND METHODS
Animals

Male C57Bl6/J mice (Jackson Laboratories) were given a normal
chow diet (ND) (13.5% calories from fat; LabDiet 5LOD) or 60%
high fat diet (HFD) (Research Diets D12492) at 6 weeks of age for
a duration of 12, 16, or 20 weeks. A third group of mice was put
on HFD for 12 weeks and then on ND for 8 weeks [weight loss
(WL) group]. Animals were housed in a specific pathogen-free
facility with a 12-h light/12-h dark cycle at ~22°C and given free
access to food and water. All animal use was in compliance with
the Institute of Laboratory Animal Research Guide for the Care
and Use of Laboratory Animals and approved by the University
Committee on Use and Care of Animals at the University of
Michigan. The tibia was selected for our longitudinal analyses
since it can be used to simultaneously monitor changes in rMAT
(proximal tibia) and cMAT (distal tibia) within one sample (37).
To compare the changes in bone within the tibia to those in the
femur, as reported previously (12), we also analyzed the femurs
in the 20-week groups.

Micro Computed-Tomography

Tibiae were fixed in formalin for 48-h and then placed in phosphate
buffered saline (PBS). Specimens were embedded in 1% agarose
and placed in a 19-mm diameter tube, and the length of the bone
was scanned using a Micro Computed-Tomography (microCT)
system (μCT100 Scanco Medical, Bassersdorf, Switzerland).
Scan settings were: voxel size 12 μm, medium resolution, 70 kVp,
114 μA, 0.5 mm AL filter, and integration time 500 ms. Density
measurements were calibrated to the manufacturer’s hydroxyapatite phantom. Analysis was performed using the manufacturer’s
evaluation software.
Femurs were removed and frozen after wrapping in PBS-soaked
gauze and then analyzed by microCT. Femora were scanned in
water using cone beam computed tomography (explore Locus SP,
GE Healthcare Pre-Clinical Imaging, London, ON, Canada). Scan
parameters included a 0.5° increment angle, four frames averaged,
an 80 kVp and 80 μA X-ray source with a 0.508 mm AI filter to
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Quantification of Marrow Adipose Tissue

reduce beam hardening artifacts, and a beam flattener around the
specimen holder. All images were reconstructed and calibrated at
an 18 μm isotropic voxel size to manufacturer-supplied phantom
of air, water, and hydroxyapatite (38).

Marrow adipose tissue volume within the tibia was assessed
as described previously (37, 40). After the initial microCT
scan, bones were decalcified in 14% EDTA solution, pH 7.4 for
14 days at 4°C. Decalcified bones were stained with 1% osmium
tetroxide solution in Sorensen’s phosphate buffer pH 7.4 at room
temperature for 48 h. Osmium-stained bones were re-scanned
using the Scanco microCT settings described above. For analysis
of MAT within the tibia, four regions were defined as follows: (1)
the proximal epiphysis between the proximal end of the tibia and
the growth plate, (2) the proximal metaphysis, beginning 60 μm
(5-slices) distal to the growth plate and ending after 600 μm total
(50-slices), (3) the growth plate to the tibia/fibula junction (GP to
T/F J), and the distal tibia between the tibia/fibula junction and
the distal end of the bone. MAT volume analyses were performed
with standard Scanco plugins with a threshold of 500.

Biomechanical Assessment

Following microCT scanning, femurs were loaded to failure in
four-point bending using a servohydraulic testing machine (MTS
858 MiniBionix, Eden Prairie, MN, USA). All specimens were
kept hydrated in lactated ringers solution-soaked gauze until
mechanical testing. In the same mid-diaphyseal region analyzed
by μCT, the femur was loaded in four-point bending with the
posterior surface oriented under tension. The distance between
the wide, upper supports was 6.26 mm, and the span between the
narrow, lower supports was 2.085 mm. The vertical displacement
rate of the four-point bending apparatus in the anterior–posterior
direction was 0.5 mm/s. Force was recorded by a 50 lb load cell
(Sensotec) and vertical displacement by an external linear variable differential transducer (LVDT, Lucas Schavitts, Hampton,
VA, USA), both at 2000 Hz. A custom MATLAB script was used
to analyze the raw force-displacement data and calculate all
four-point bending parameters. Combining anterior–posterior
bending moment of inertia data from μCT with mechanical stiffness from four point bending, the estimated elastic modulus was
calculated using standard beam theory as previously described
(38). The modulus of elasticity was derived based on previous
methods with “L” set at 3.57 and “a” at 0.99 (39).

Statistics

Statistical comparisons were performed in GraphPad Prism
(GraphPad Software, Inc., La Jolla, CA, USA). The following
planned comparisons were performed on the graphs in Figures 1,
2, 3 and 5: 12-week ND vs. HFD (two-tailed t-test); 16-week
ND vs. HFD (two-tailed t-test); 20-week ND vs. HFD vs. WL
(1-way ANOVA); 12-, 16-, 20-week ND (1-way ANOVA); 12-,
16-, 20-week HFD (1-way ANOVA); 12-week HFD vs. 20-week
WL (two-tailed t-test). These results were corrected for multiple comparisons using the Benjamini-Hochberg procedure as
described previously (41). For comparisons in Figures 4, 6 and
7, a one-way ANOVA with Tukey’s correction was applied. In
Figure 8, linear regression was applied to test the significance of
the correlations. Raw data for the skeletal morphology, marrow
fat quantification, and biomechanical testing is available in Data
Sets 1–3 in Supplementary Material.

Quantification of Trabecular and Cortical
Parameters with microCT

Tibia. Regions of interest (ROI) was located for both cortical and
trabecular parameters. Analyses were performed with MicroCT
software provided by Scanco Medical (Bassersdorf, Switzerland).
A mid-diaphyseal cortical ROI was defined as ending at 70% of
the distance between the growth plate and the tibia/fibula junction. A ROI spanning 360 μm (30-slices) proximal to this region
was analyzed with standard plugins using a threshold of 280. The
trabecular ROI was defined as starting 60 μm (5-slices) distal
to the growth plate and ending after 600 μm total (50-slices).
Trabecular analyses were performed with standard Scanco
plugins with a threshold of 180.
Femur. ROI was located for both cortical and trabecular parameters. A diaphyseal cortical ROI spanning 18% of total femur
length was located midway between the distal growth plate and
third trochanter. Cortical bone was isolated with a fixed threshold
of 2000 Hounsfield Units for all experimental groups. Parameters
including cortical thickness, endosteal and periosteal perimeter,
cross sectional area, marrow area, total area, anterior–posterior
bending moment of inertia, and tissue mineral density (TMD)
were quantified with commercially available software (MicroView
v2.2 Advanced Bone Analysis Application, GE Healthcare PreClinical Imaging, London, ON, Canada). A trabecular ROI 10%
of total femur length was located immediately proximal to the
distal femoral growth plate and defined along the inner cortical
surface with a splining algorithm. Trabecular metaphyseal bone
was isolated with a fixed threshold of 1200 Hounsfield Units.
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RESULTS
Increases in Body Mass with High-Fat Diet
Are Rescued by Weight Loss

Mice were fed normal chow diet (ND) or 60% high-fat diet (HFD),
starting at 6 weeks of age, for 12, 16, or 20 weeks. A separate group
of mice received 12 weeks of HFD, followed by 8 weeks of ND
to mimic weight loss (Figure 1A). Comparison of the 12-week
HFD group to the WL group was used to determine if weight loss
reversed changes that were already present at 12 weeks, or, rather,
prevented further deterioration induced by continued HFD.
Increases in body mass relative to ND control were apparent
after 12-weeks of HFD (Figure 1B). Increases in body mass relative to ND control persisted at the 16- and 20-week time points
(Figure 1B). Over time, body mass continued to increase from
12 to 16 weeks of HFD but stabilized between 16 and 20 weeks
(Figure 1B). Body mass returned to normal after weight loss
(Figure 1B). Weight gain was due, at least in part, to increases
in liver, inguinal and gonadal white adipose tissue (WAT) mass
after 20-weeks of HFD (Figure 1C). With weight loss, liver mass
returned to normal; however, WAT mass was only partially
rescued (Figure 1C).
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Figure 1 | Body and tissue mass. (A) Experiment outline. Starting at 6-weeks of age, mice were fed the indicated diets for up to 20 weeks prior to analysis.
Seven groups of mice were analyzed as indicated by the dashed lines. ND: normal chow diet; HFD: high fat diet; WL: weight loss. (B) Body mass. N = 7-8 per
group. (C) Tissue mass at 20 weeks. N = 4-6 per group. All graphs are mean ± SEM. “a” – significant vs. 12-week on same diet. “b” – significant vs. 16-week on
same diet. “c” – significant vs. 12-week HFD. *p < 0.050 for the indicated comparison.

Marrow Adipose Tissue Expansion after
High-Fat Diet Feeding Is Inhibited
with Weight Loss

tibia at 20-weeks (Figure 2B). Raw data for these comparisons is
available as Data Set 1 in Supplementary Material.

In the Tibia, Trabecular Bone Quality
Decreases with High-Fat Diet and Partially
Improves with Weight Loss

Within the tibia, MAT expansion became significant, relative to
ND control, after 16 weeks of HFD (Figures 2A,B). With HFD,
changes in the proximal tibial epiphysis mimicked what was
observed between the growth plate and tibia/fibula junction,
with a 5.5- and 4.3-fold increase at 16 weeks, relative to 12 weeks,
respectively (Figure 2B). The distal tibia was similar, though
there was only a 2.1-fold increase between 12 and 16 weeks of
HFD, likely owing to the higher baseline MAT in this region
(Figure 2B). No additional MAT accrual in any region of the
tibia was observed between 16 and 20 weeks of HFD (Figure 2B).
In the weight loss group, the MAT in the regions of the proximal
epiphysis and GP to T/F J was indistinguishable from that of the
20-week ND group (Figure 2B). However, it was also similar in
magnitude to the 12-week HFD group, suggesting that switching to
ND was sufficient to block HFD-induced MAT expansion – rather
than reversing MAT accrual that had already occurred.
In the distal tibia, age-associated increases in MAT were noted
from 12- to 16-weeks of age in the ND group. Prior to correction for multiple comparisons, MAT within the distal tibia in
the WL group was higher than chow (p = 0.019) but less than
HFD (p = 0.050). This suggests that weight loss blunted, but did
not entirely prevent, HFD-induced MAT expansion in the distal

Frontiers in Endocrinology | www.frontiersin.org

Consistent with previous reports (42, 43), we observed an
age-related decrease in trabecular bone volume fraction (BVF)
and trabecular number, with a corresponding increase in
spacing, in the proximal tibial metaphysis of ND control mice
(Figures 3A,C,E,G).
Relative to ND controls, mice fed a HFD had a significant
decrease in trabecular BVF, bone mineral content (BMC), and
number after 12-weeks of diet (Figures 3C,D,E). Structure
model index and trabecular spacing were reciprocally increased
(Figures 3F,G). Trabecular thickness remained unchanged (Data
Set 1 in Supplementary Material). Loss of trabecular BVF and
BMC with HFD, relative to control ND, persisted at the 16- and
20-week time points (Figures 3C–G). Weight loss partially rescued
decreases in trabecular BVF, BMC, and number (Figures 3C–E)
and increases in spacing (Figure 3G).
Unlike loss of trabecular bone at 12-weeks, MAT volume was
not significantly increased relative to ND control until 16- and
20-weeks of HFD (Figure 3B). Over time, MAT increased by 3.5fold from 12- to 16-weeks of age in the HFD group (Figure 3B).

4
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Figure 2 | Region-specific changes in MAT volume with HFD and WL. (A) 3D reconstruction of osmium tetroxide stained MAT (dark gray) overlaid on the
tibia bone (light gray). (B) Region-specific quantification of MAT in the proximal tibial epiphysis, between the growth plate to tibia/fibula junction (GP to T/F J), and the
distal tibia. All graphs are mean ± SEM. N = 3-6 per group for the proximal epiphysis; low N is due to accidental removal/fracture of the proximal epiphysis during
processing. N = 6–8 for all other groups. ND, normal chow diet; HFD, high-fat diet; WL, weight loss. “a” – significant vs. 12-week on same diet. “b” – significant vs.
16-week on same diet. “c” – significant vs. 12-week HFD. *p < 0.050 for the indicated comparison.

(Figure 4A). The absolute amount of MAT in the distal femoral
metaphysis was ~90% less than the proximal tibia (p < 0.0001,
t-test) (Figures 3B and 4A). The magnitude of the loss of BVF
with HFD at 20-weeks was comparable between femur and tibia
(50 vs. 45%) (Figure 4B; Data Sets 1 and 2 in Supplementary
Material). There was also a significant, HFD-induced decrease
in trabecular number and increase in trabecular spacing
(Figures 4D,F). Trabecular thickness and tissue mineral density
remained unchanged (Figures 4C,E). With weight loss, there were
no statistically significant differences in trabecular morphology,

No further increases were present from 16- to 20-weeks of age.
Weight loss completely prevented HFD-induced MAT accumulation from 12- to 20-weeks (Figure 3B).

In the Femur, Trabecular Bone Quality
Decreases with High-Fat Diet and after
Weight Loss

Relative to ND control, HFD caused MAT expansion within the
femur (Figure 4A). MAT expansion was absent in the WL group

Frontiers in Endocrinology | www.frontiersin.org

5

July 2016 | Volume 7 | Article 102

Scheller et al.

Skeletal Changes in Obesity

Figure 3 | Changes in MAT and trabecular architecture at the proximal tibial metaphysis over time. (A) Representative images of trabecular architecture
and MAT at the 20-week time point. Images of trabeculae and MAT are from the same bone for a given diet. (B–G) Quantification of MAT and trabecular parameters
in the proximal metaphysis of the tibia. All graphs are mean ± SEM. N = 7–8 per group. ND: normal chow diet; HFD: high-fat diet; WL: weight loss. “a” – significant
vs. 12-week on same diet. “b” – significant vs. 16-week on same diet. “c” – significant vs. 12-week HFD. *p < 0.050 for the indicated comparison.
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Figure 4 | Changes in MAT and trabecular architecture at the distal femoral metaphysis at 20-weeks. (A–F) Quantification of MAT and trabecular
parameters in the distal metaphysis of the femur. All graphs are mean ± SEM. N = 8 per group. ND, normal chow diet; HFD, high-fat diet; WL, weight loss.
*p < 0.050 for the indicated comparison.

Marrow Adipose Tissue Expansion
Correlates with Bone Loss in the Tibia

relative to HFD, in the femur (Figures 4B–F). There was a nonsignificant trend toward a decrease in trabecular spacing in the
WL group relative to HFD (Figure 4F).

In the control ND group, pooled over all ages (12, 16, and 20 weeks
of diet), there was a significant inverse correlation between MAT
volume in the proximal metaphysis and measures of trabecular
morphology including BVF, trabecular thickness, and BMC – but
not with trabecular number (Figures 7A–D). By contrast, in the
HFD group, MAT volume was negatively correlated with trabecular BVF, thickness, and BMC in addition to trabecular number
(Figures 7A–D). Cortical thickness was significantly negatively
correlated with GP to T/F J MAT volume in the HFD group only
(Figure 7E). Cortical TMD did not correlate with MAT volume
in either group (Figure 7F).

Changes in Cortical Bone after
High-Fat Diet and Weight Loss

Within the tibia, there were no statistically significant changes
in mid-diaphyseal cortical morphology after 12, 16, or 20 weeks
of HFD or after weight loss (Figures 5A–F). However, slight
differences may have been missed after statistical correction
for multiple comparisons. For example, with standard one-way
ANOVA at the 20-week time point only, there was a slight
decrease in cortical thickness in the 20-week HFD group relative
to ND control (p = 0.045) (Figure 5D). Raw data are available in
Data Set 1 in Supplementary Material.
In the femur, 20-week HFD caused a significant decrease in
cortical thickness relative to ND control (Figure 6D). Cortical
tissue mineral density was also decreased with HFD (Figure 6F).
With weight loss, cortical thickness and total mineral density
improved relative to ND (Figures 6D,F). No differences in total
area, marrow area, cortical area, or Iyy were noted (Figures 6A–F).
Raw data are available in Data Set 2 in Supplementary Material.

Frontiers in Endocrinology | www.frontiersin.org

High-Fat Diet Causes Persistent
Decreases in Biomechanical
Properties of the Femur

Four-point bending was performed to assess the biomechanical
integrity of HFD and WL femurs. The femurs from the 20-week
HFD and WL groups broke under a reduced maximum load
relative to ND, trending toward less total work to induce fracture
(Figures 8A,B). This indicates that despite recovery of cortical

7

July 2016 | Volume 7 | Article 102

Scheller et al.

Skeletal Changes in Obesity

Figure 5 | Changes in cortical morphology at the mid-tibial diaphysis. (A–F) Quantification of cortical parameters in the mid-diaphysis of the tibia. N = 7–8
per group. ND: normal chow diet; HFD: high-fat diet; WL: weight loss. All graphs are mean ± SEM. “a” – significant vs. 12-week on same diet. “b” – significant vs.
16-week on same diet. “c” – significant vs. 12-week HFD. *p < 0.050 for the indicated comparison.

thickness and mineral density with WL (Figure 6), the bone
quality remains impaired, leading to decreased fracture resistance and poor post-yield behavior. The yield load and post-yield
work trended toward a decrease relative to ND in the HFD and
WL groups, respectively (p < 0.1) (Figures 8D,E). The stiffness,
post-yield displacement, and modulus of elasticity (39) were not
significantly different between groups (Figures 8C,F) (Data Set 3
in Supplementary Material).

that dysfunction of peripheral tissues (e.g., insulin resistance)
occurs prior to HFD-induced MAT expansion.
As adipocytes and osteoblasts arise from the same mesenchymal progenitor cell, the notion of “fate-switching” whereby
one lineage is favored over the other has been suggested
(29–31). The inhibition of osteoblast differentiation may
subsequently lead to increased adipocyte production, thus
presenting with a situation of reduced bone mass and increased
MAT (44). It is of note that this concept fails to capture the
complexity of skeletal progenitors – some of which have the
capacity to differentiate into osteoblasts but not adipocytes
(45). In our study we observed the well-documented inverse
correlation between MAT volume and bone mass/density in
the tibia (Figure 7). However, despite this correlation, our data
do not support the hypothesis that MAT expansion is the sole
mediator of bone loss with HFD. Specifically, deterioration of
trabecular architecture occurred as early as 12-weeks after HFD
in the tibia, while changes in MAT did not become statistically
significant until 16 weeks (Figures 2 and 3). Furthermore,

DISCUSSION
To our knowledge, this is the first study that has measured, within
the same bone, HFD-induced MAT expansion and changes in
skeletal morphology. By incorporating a weight loss group, we
were also able to inhibit MAT expansion, and thus examine the
impact of HFD on bone quality in the absence of MAT accumulation. In this study, HFD caused increases in body mass at
12-weeks, indicating accumulation of peripheral adiposity. This
occurred prior to increases in MAT, supporting the hypothesis

Frontiers in Endocrinology | www.frontiersin.org
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Figure 6 | Changes in cortical morphology at the mid-femoral diaphysis. (A–F) Quantification of cortical parameters in the mid-diaphysis of the femur. N = 8
per group. ND, normal chow diet; HFD, high-fat diet; WL, weight loss. All graphs are mean ± SEM. *p < 0.050 for the indicated comparison.

though switching from HFD to chow at 12-weeks completely
prevented HFD-induced MAT accumulation in the WL group
(Figure 3B), loss of trabecular number and corresponding
increases in trabecular spacing beyond that of controls still
occurred (Figures 3E,G). Thus, in this context, inhibition
of MAT expansion by weight loss was not sufficient to block
HFD-induced decreases in trabecular bone within the tibial
metaphysis.
There are many MAT-independent effects with the potential to regulate bone during high-fat feeding, the presence
of which may contribute to the cancellous and cortical bone
loss observed in this model. Increased fat mass is associated
with increased systemic markers of oxidative stress in both
humans and mice (4). Increased peroxide (H2O2) and reduced
endothelial nitric oxide synthase in a genetic model of obesity
was associated with cancellous bone loss (46). Reactive oxygen
species have been found to promote the association of the transcription factors FoxO with β-catenin, subsequently leading to
a reduction in Wnt signaling and osteoblastic differentiation
(47). Although the direct effects of leptin may also promote
osteoblast proliferation and differentiation (25, 48), the central
effects of leptin have been shown to mediate the opposite
effects, promoting cancellous bone loss via the sympathetic
nervous system (23, 24). Another central pathway involving
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increased neuropeptide Y (NPY) arising from leptin resistance
during obesity is implicated in bone metabolism as mice with
increased central NPY have concurrent obesity with bone loss
(49) and NPY deficiency in ob/ob mice leads to improved cortical bone mass (50).
Lastly, there is an increase in systemic inflammation with obesity that might directly affect bone marrow osteoclasts. A major
source of obesity-induced inflammation stems from an increase
in bone marrow macrophages and their progenitors (51). These
bone marrow-derived macrophages during obesity mediate an
inflammatory environment that has been shown to stimulate
osteoclastogenesis and reduce osteoblast development (52, 53),
possibly due to the expansion of the common monocyte-osteoclast progenitor (54). Recently, Yue et al. have also demonstrated
that leptin produced from obese adipose tissue can directly bind
to leptin receptors on mesenchymal stem cells promoting differentiation of adipocytes and inhibiting osteoblast formation (29).
Altogether there are a number of MAT-independent variables
involved in coordinating the relationship between diet-induced
obesity and bone.
Though it is not the sole mediator of bone loss with HFD, our
study does not rule out the possibility that MAT, particularly
when present in large excess, may exert detrimental effects on
bone. Indeed, the magnitude of cancellous bone loss in the
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Figure 7 | MAT vs. bone over time with control or high-fat diet. (A–D) Correlation between marrow adipose tissue volume in the proximal metaphysis and
trabecular parameters. (E,F) Correlation between marrow adipose tissue volume between the growth plate and tibia/fibula junction and cortical parameters in the
same bone. Data grouped by diet type. ND: normal diet control for 12, 16and 20 weeks. HFD: high-fat diet for 12, 16, and 20 weeks. Linear regression. *p < 0.050
for the indicated diet.

tibia (Figure 3) and cortical bone loss in the femur (Figure 6)
was significantly greater in the 20-week HFD group with MAT
expansion than the WL group in which MAT expansion failed
to occur. Comparisons between the femur and tibia provide
further clues as to this relationship. Consistent with a previous
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report, 12-weeks of HFD followed by 8-weeks of normal chow
diet (WL group) did not prevent cancellous bone loss in the distal femoral metaphysis (12). By contrast, in the same animals,
weight loss partially prevented HFD-induced deterioration of
trabecular BVF and BMC in the tibia (Figure 3). It is possible
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Figure 8 | Femur biomechanical testing at 20 weeks. (A–F) Quantification of biomechanical parameters, as assessed by four-point bending. N = 12–14 per
group. ND, normal chow diet; HFD, high-fat diet; WL, weight loss. All graphs are mean ± SEM. *p < 0.050 for the indicated comparison.

that this discrepancy may be explained by differences in MAT.
After 20-weeks of HFD, the volume of MAT in the metaphysis
of the tibia was 9.8-fold greater than in the femur. This is similar
to previous work by Halade et al., despite substantial differences in their model system (10% corn oil diet for 24-weeks
in 12-month-old female mice) (44). Thus, it is possible that
this increase in MAT contributed to additional bone loss in the
tibia, beyond that observed in the femur, subsequently leading
to a difference between the HFD and WL groups. However,
given previous work, the nuances of this observation remain
unclear (44).
Direct interactions between MAT and bone may influence
bone loss during high fat feeding. Recently, MAT was found to
be a significant contributor of circulating adiponectin during
calorie restriction (55), this emphasizes the potential of MAT to
influence not only bone but also whole body homeostasis. Direct
adipose-bone pathways have been demonstrated to influence
bone mass; the main two adipokines implicated are leptin (29,
48, 56–58) and adiponectin (59–61). More locally within the bone
microenvironment, in vitro experiments have demonstrated that
the release of free fatty acids from adipocytes inhibited osteoblast
differentiation and promoted apoptosis through ROS production
(62). Interestingly, co-cultures of osteoblasts and osteoclasts with
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adipocytes suggest that in addition to reducing osteoblastogenesis, osteoclastogenesis may be increased with increased adiposity, resulting in reduced bone mass (31).
Biomechanically, weight loss after 12-weeks of HFD was
insufficient to rescue impaired fracture resistance. Indeed,
the maximum load endured by the HFD and WL femurs was
nearly identical – despite almost complete recovery of body
mass and prevention of MAT expansion in the WL group.
Comparable stiffness and modulus of elasticity in the ND, WL,
and HFD groups indicates that the elastic properties of the
bone were not affected. However, the failure properties were
similarly reduced in both the HFD and WL groups, despite
differential rescue of tissue mineral density and cortical
thickness, implying that femur architecture fails to explain the
impaired biomechanics. This may point to dysfunction within
the organic properties of the bone, such as impaired crosslinking of collagen (26), as a potential mediator of persistent
HFD-induced fracture risk.
Our study demonstrates that HFD causes long-term, persistent changes in bone quality. We started HFD at an age in which
skeletal development is still highly active, likely contributing
to impaired bone accrual during growth. Indeed, diet-induced
obesity causes greater damage in growing bones (63). This
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is an important finding given the rise of obesity in pediatric
populations (2, 64). Furthermore, these data demonstrate that
MAT is not necessary for HFD-induced bone loss; however,
MAT expansion, when present, may contribute to additional
skeletal deterioration. It is likely that changes within the bone
microenvironment including the adipocytes themselves are

being altered but this was not examined in the current study
(31, 65) and will need to be evaluated with future mechanistic
investigations.
Given the rise in obesity across the age spectrum, this is a critical area of research and future studies are needed to determine
the effects of weight loss (dietary or surgical) on bone density
and to understand the mechanisms that drive changes in bone
health. Even with the limitations a clear finding in this study is
that there are some reversible and some permanent changes with
HFD, followed by WL. Different regimens may be required to
maintain bone health after WL, possibly with a focus on activity
and diet (36).
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